| (Values in U.S. Thousands) | Jun, 2024 | Jun, 2023 | Jun, 2022 | Jun, 2021 | Jun, 2020 |
| Sales | 4,685,300 | 4,222,990 | 3,578,130 | 3,196,830 | 2,957,010 |
| Sales Growth | +10.95% | +18.02% | +11.93% | +8.11% | +13.44% |
| Net Income | 1,020,950 | 897,560 | 779,440 | 474,510 | 621,670 |
| Net Income Growth | +13.75% | +15.15% | +64.26% | -23.67% | +53.65% |
Resmed Inc (RMD)
215.23 x 1 229.77 x 1
Post-market by (Cboe BZX)
221.88 +0.59 (+0.27%) 03/26/25 [NYSE]
215.23 x 1 229.77 x 1
Post-market 221.60 -0.28 (-0.13%) 19:16 ET
for Wed, Mar 26th, 2025
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Fiscal Year End Date: 06/30